DexCom Inc (DXCM)
128.38
+1.76
(+1.39%)
USD |
NASDAQ |
May 03, 16:00
128.38
0.00 (0.00%)
After-Hours: 19:37
DexCom Free Cash Flow: 583.50M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 583.50M |
December 31, 2023 | 511.90M |
September 30, 2023 | 499.80M |
June 30, 2023 | 466.00M |
March 31, 2023 | 416.00M |
December 31, 2022 | 304.70M |
September 30, 2022 | 261.30M |
June 30, 2022 | 215.50M |
March 31, 2022 | 94.60M |
December 31, 2021 | 53.30M |
September 30, 2021 | 139.50M |
June 30, 2021 | 100.50M |
March 31, 2021 | 236.00M |
December 31, 2020 | 276.60M |
September 30, 2020 | 264.40M |
June 30, 2020 | 209.00M |
March 31, 2020 | 130.70M |
December 31, 2019 | 134.50M |
September 30, 2019 | 50.90M |
June 30, 2019 | 39.10M |
March 31, 2019 | 52.60M |
December 31, 2018 | 56.10M |
September 30, 2018 | 63.70M |
June 30, 2018 | 53.40M |
March 31, 2018 | 24.60M |
Date | Value |
---|---|
December 31, 2017 | 26.00M |
September 30, 2017 | -1.90M |
June 30, 2017 | -17.70M |
March 31, 2017 | -10.40M |
December 31, 2016 | 0.50M |
September 30, 2016 | 4.50M |
June 30, 2016 | 8.10M |
March 31, 2016 | 8.60M |
December 31, 2015 | 15.70M |
September 30, 2015 | 19.80M |
June 30, 2015 | 17.00M |
March 31, 2015 | 9.10M |
December 31, 2014 | 7.40M |
September 30, 2014 | 5.70M |
June 30, 2014 | -2.60M |
March 31, 2014 | -5.90M |
December 31, 2013 | -5.50M |
September 30, 2013 | -19.60M |
June 30, 2013 | -27.90M |
March 31, 2013 | -36.00M |
December 31, 2012 | -42.60M |
September 30, 2012 | -45.69M |
June 30, 2012 | -45.03M |
March 31, 2012 | -39.52M |
December 31, 2011 | -38.10M |
Free Cash Flow Range, Past 5 Years
39.10M
Minimum
Jun 2019
583.50M
Maximum
Mar 2024
249.39M
Average
225.75M
Median
Free Cash Flow Benchmarks
Edwards Lifesciences Corp | 251.20M |
Abbott Laboratories | 5.059B |
Cardinal Health Inc | 3.421B |
Intuitive Surgical Inc | 595.80M |
Insulet Corp | 36.50M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 209.20M |
Cash from Investing (Quarterly) | 74.80M |
Cash from Financing (Quarterly) | 4.70M |
Free Cash Flow Per Share (Quarterly) | 0.3655 |
Free Cash Flow to Equity (Quarterly) | 150.50M |
Free Cash Flow to Firm (Quarterly) | 152.30M |
Free Cash Flow Yield | 1.07% |